Which has higher earnings and valuation, ALMR or MIR?

Mirion Technologies has higher revenue and earnings than Alamar Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alamar Biosciences $87.16M 17.50 N/A N/A N/A Mirion Technologies $925.40M 4.49 $28.80M $0.10 165.98

Which has preferable earnings and valuation, ALMR or VNT?

Vontier has higher revenue and earnings than Alamar Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alamar Biosciences $87.16M 17.50 N/A N/A N/A Vontier $3.08B 1.34 $406.10M $2.83 10.32

Which has stronger valuation and earnings, ALMR or TXG?

Alamar Biosciences has higher earnings, but lower revenue than 10x Genomics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alamar Biosciences $87.16M 17.50 N/A N/A N/A 10x Genomics $642.82M 5.70 -$43.54M -$0.17 N/A

Which has preferable earnings and valuation, AEHR or ALMR?

Alamar Biosciences has higher revenue and earnings than Aehr Test Systems. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aehr Test Systems $58.97M 57.85 -$3.91M -$0.38 N/A Alamar Biosciences $87.16M 17.50 N/A N/A N/A

Which has higher valuation and earnings, ALNT or ALMR?

Allient has higher revenue and earnings than Alamar Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Allient $560.59M 2.77 $22.03M $1.43 63.90 Alamar Biosciences $87.16M 17.50 N/A N/A N/A

Alamar Biosciences (ALMR) Competitors

$22.00 0.00 (0.00%)

As of 06/12/2026 04:00 PM Eastern

Compare

ALMR vs. MIR, VNT, TXG, AEHR, and ALNT

Should you buy Alamar Biosciences stock or one of its competitors? MarketBeat compares Alamar Biosciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alamar Biosciences include Mirion Technologies (MIR), Vontier (VNT), 10x Genomics (TXG), Aehr Test Systems (AEHR), and Allient (ALNT). These companies are all part of the "measuring and control equipment" industry.

How does Alamar Biosciences compare to Mirion Technologies?

Alamar Biosciences (NASDAQ:ALMR) and Mirion Technologies (NYSE:MIR) are both measuring and control equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.

78.5% of Mirion Technologies shares are owned by institutional investors. 2.2% of Mirion Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Mirion Technologies had 6 more articles in the media than Alamar Biosciences. MarketBeat recorded 7 mentions for Mirion Technologies and 1 mentions for Alamar Biosciences. Alamar Biosciences' average media sentiment score of 1.87 beat Mirion Technologies' score of 1.59 indicating that Alamar Biosciences is being referred to more favorably in the media.

Company	Overall Sentiment
Alamar Biosciences	Very Positive
Mirion Technologies	Very Positive

Mirion Technologies has a net margin of 2.56% compared to Alamar Biosciences' net margin of 0.00%. Mirion Technologies' return on equity of 6.44% beat Alamar Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alamar Biosciences	N/A	N/A	N/A
Mirion Technologies	2.56%	6.44%	3.48%

Alamar Biosciences currently has a consensus target price of $30.00, suggesting a potential upside of 36.36%. Mirion Technologies has a consensus target price of $27.13, suggesting a potential upside of 63.42%. Given Mirion Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Mirion Technologies is more favorable than Alamar Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Mirion Technologies	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80

Mirion Technologies has higher revenue and earnings than Alamar Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alamar Biosciences	$87.16M	17.50	N/A	N/A	N/A
Mirion Technologies	$925.40M	4.49	$28.80M	$0.10	165.98

Summary

Mirion Technologies beats Alamar Biosciences on 11 of the 13 factors compared between the two stocks.

How does Alamar Biosciences compare to Vontier?

Alamar Biosciences (NASDAQ:ALMR) and Vontier (NYSE:VNT) are both measuring and control equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, institutional ownership, dividends, profitability and earnings.

95.8% of Vontier shares are owned by institutional investors. 1.1% of Vontier shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Alamar Biosciences presently has a consensus price target of $30.00, suggesting a potential upside of 36.36%. Vontier has a consensus price target of $42.38, suggesting a potential upside of 45.07%. Given Vontier's higher probable upside, analysts clearly believe Vontier is more favorable than Alamar Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Vontier	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.40

Vontier has higher revenue and earnings than Alamar Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alamar Biosciences	$87.16M	17.50	N/A	N/A	N/A
Vontier	$3.08B	1.34	$406.10M	$2.83	10.32

In the previous week, Vontier had 9 more articles in the media than Alamar Biosciences. MarketBeat recorded 10 mentions for Vontier and 1 mentions for Alamar Biosciences. Alamar Biosciences' average media sentiment score of 1.87 beat Vontier's score of 0.69 indicating that Alamar Biosciences is being referred to more favorably in the media.

Company	Overall Sentiment
Alamar Biosciences	Very Positive
Vontier	Positive

Vontier has a net margin of 13.37% compared to Alamar Biosciences' net margin of 0.00%. Vontier's return on equity of 37.88% beat Alamar Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alamar Biosciences	N/A	N/A	N/A
Vontier	13.37%	37.88%	10.90%

Summary

Vontier beats Alamar Biosciences on 9 of the 12 factors compared between the two stocks.

How does Alamar Biosciences compare to 10x Genomics?

Alamar Biosciences (NASDAQ:ALMR) and 10x Genomics (NASDAQ:TXG) are both measuring and control equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, media sentiment and earnings.

Alamar Biosciences currently has a consensus target price of $30.00, suggesting a potential upside of 36.36%. 10x Genomics has a consensus target price of $23.17, suggesting a potential downside of 19.67%. Given Alamar Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe Alamar Biosciences is more favorable than 10x Genomics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
10x Genomics	1 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.20

84.7% of 10x Genomics shares are owned by institutional investors. 8.8% of 10x Genomics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, 10x Genomics had 9 more articles in the media than Alamar Biosciences. MarketBeat recorded 10 mentions for 10x Genomics and 1 mentions for Alamar Biosciences. Alamar Biosciences' average media sentiment score of 1.87 beat 10x Genomics' score of 0.77 indicating that Alamar Biosciences is being referred to more favorably in the media.

Company	Overall Sentiment
Alamar Biosciences	Very Positive
10x Genomics	Positive

Alamar Biosciences has a net margin of 0.00% compared to 10x Genomics' net margin of -3.55%. Alamar Biosciences' return on equity of 0.00% beat 10x Genomics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alamar Biosciences	N/A	N/A	N/A
10x Genomics	-3.55%	-2.86%	-2.23%

Alamar Biosciences has higher earnings, but lower revenue than 10x Genomics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alamar Biosciences	$87.16M	17.50	N/A	N/A	N/A
10x Genomics	$642.82M	5.70	-$43.54M	-$0.17	N/A

Summary

Alamar Biosciences beats 10x Genomics on 7 of the 11 factors compared between the two stocks.

How does Alamar Biosciences compare to Aehr Test Systems?

Aehr Test Systems (NASDAQ:AEHR) and Alamar Biosciences (NASDAQ:ALMR) are both measuring and control equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

Alamar Biosciences has higher revenue and earnings than Aehr Test Systems.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aehr Test Systems	$58.97M	57.85	-$3.91M	-$0.38	N/A
Alamar Biosciences	$87.16M	17.50	N/A	N/A	N/A

Alamar Biosciences has a net margin of 0.00% compared to Aehr Test Systems' net margin of -25.23%. Alamar Biosciences' return on equity of 0.00% beat Aehr Test Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aehr Test Systems	-25.23%	-7.15%	-6.15%
Alamar Biosciences	N/A	N/A	N/A

Aehr Test Systems presently has a consensus target price of $68.00, suggesting a potential downside of 37.31%. Alamar Biosciences has a consensus target price of $30.00, suggesting a potential upside of 36.36%. Given Alamar Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Alamar Biosciences is more favorable than Aehr Test Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aehr Test Systems	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

69.7% of Aehr Test Systems shares are held by institutional investors. 6.8% of Aehr Test Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Aehr Test Systems had 2 more articles in the media than Alamar Biosciences. MarketBeat recorded 3 mentions for Aehr Test Systems and 1 mentions for Alamar Biosciences. Alamar Biosciences' average media sentiment score of 1.87 beat Aehr Test Systems' score of 1.11 indicating that Alamar Biosciences is being referred to more favorably in the news media.

Company	Overall Sentiment
Aehr Test Systems	Positive
Alamar Biosciences	Very Positive

Summary

Alamar Biosciences beats Aehr Test Systems on 8 of the 12 factors compared between the two stocks.

How does Alamar Biosciences compare to Allient?

Allient (NASDAQ:ALNT) and Alamar Biosciences (NASDAQ:ALMR) are both small-cap measuring and control equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.

In the previous week, Allient had 2 more articles in the media than Alamar Biosciences. MarketBeat recorded 3 mentions for Allient and 1 mentions for Alamar Biosciences. Alamar Biosciences' average media sentiment score of 1.87 beat Allient's score of 0.62 indicating that Alamar Biosciences is being referred to more favorably in the news media.

Company	Overall Sentiment
Allient	Positive
Alamar Biosciences	Very Positive

61.6% of Allient shares are owned by institutional investors. 15.0% of Allient shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Allient has higher revenue and earnings than Alamar Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allient	$560.59M	2.77	$22.03M	$1.43	63.90
Alamar Biosciences	$87.16M	17.50	N/A	N/A	N/A

Allient has a net margin of 4.25% compared to Alamar Biosciences' net margin of 0.00%. Allient's return on equity of 12.47% beat Alamar Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allient	4.25%	12.47%	6.37%
Alamar Biosciences	N/A	N/A	N/A

Allient presently has a consensus target price of $77.33, indicating a potential downside of 15.36%. Alamar Biosciences has a consensus target price of $30.00, indicating a potential upside of 36.36%. Given Alamar Biosciences' higher possible upside, analysts clearly believe Alamar Biosciences is more favorable than Allient.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allient	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

Allient beats Alamar Biosciences on 7 of the 10 factors compared between the two stocks.

Get Alamar Biosciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALMR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALMR vs. The Competition

Export

Metric	Alamar Biosciences	Lab Analytical Instruments Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$1.52B	$1.52B	$4.29B	$12.05B
Dividend Yield	N/A	N/A	10.25%	5.66%
P/E Ratio	N/A	N/A	22.29	24.42
Price / Sales	17.50	17.50	159.54	118.72
Price / Cash	N/A	N/A	40.19	37.92
Price / Book	N/A	N/A	26.92	6.82
Net Income	N/A	N/A	$116.61M	$337.56M
7 Day Performance	14.52%	14.52%	0.25%	1.16%
1 Month Performance	2.14%	2.14%	0.25%	3.16%
1 Year Performance	N/A	N/A	14.25%	30.60%

Alamar Biosciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALMR Alamar Biosciences	4.7592 of 5 stars	$22.00 flat	$30.00 +36.4%	N/A	$1.52B	$87.16M	N/A	222
MIR Mirion Technologies	4.3603 of 5 stars	$17.05 -6.4%	$27.13 +59.1%	-16.7%	$4.28B	$925.40M	38.82	3,281	Positive News
VNT Vontier	4.3225 of 5 stars	$28.19 -0.5%	$42.38 +50.3%	-17.6%	$3.96B	$3.08B	9.96	7,800
TXG 10x Genomics	1.9131 of 5 stars	$31.04 -7.3%	$23.17 -25.4%	+177.0%	$3.94B	$642.82M	N/A	1,240	Gap Up
AEHR Aehr Test Systems	1.965 of 5 stars	$98.45 -15.6%	$68.00 -30.9%	+858.2%	$3.10B	$58.97M	N/A	90	Positive News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALMR) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alamar Biosciences (ALMR) Competitors

ALMR vs. MIR, VNT, TXG, AEHR, and ALNT

How does Alamar Biosciences compare to Mirion Technologies?

Summary

How does Alamar Biosciences compare to Vontier?

Summary

How does Alamar Biosciences compare to 10x Genomics?

Summary

How does Alamar Biosciences compare to Aehr Test Systems?

Summary

How does Alamar Biosciences compare to Allient?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALMR vs. The Competition

Alamar Biosciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alamar Biosciences (ALMR) Competitors

ALMR vs. MIR, VNT, TXG, AEHR, and ALNT

How does Alamar Biosciences compare to Mirion Technologies?

Do insiders and institutionals have more ownership in ALMR or MIR?

Does the media prefer ALMR or MIR?

Is ALMR or MIR more profitable?

Do analysts rate ALMR or MIR?

Which has higher earnings and valuation, ALMR or MIR?

Summary

How does Alamar Biosciences compare to Vontier?

Do insiders and institutionals have more ownership in ALMR or VNT?

Do analysts prefer ALMR or VNT?

Which has preferable earnings and valuation, ALMR or VNT?

Does the media prefer ALMR or VNT?

Is ALMR or VNT more profitable?

Summary

How does Alamar Biosciences compare to 10x Genomics?

Do analysts prefer ALMR or TXG?

Do insiders & institutionals have more ownership in ALMR or TXG?

Does the media prefer ALMR or TXG?

Is ALMR or TXG more profitable?

Which has stronger valuation and earnings, ALMR or TXG?

Summary

How does Alamar Biosciences compare to Aehr Test Systems?

Which has preferable earnings and valuation, AEHR or ALMR?

Is AEHR or ALMR more profitable?

Do analysts rate AEHR or ALMR?

Do insiders & institutionals have more ownership in AEHR or ALMR?

Does the media favor AEHR or ALMR?

Summary

How does Alamar Biosciences compare to Allient?

Does the media refer more to ALNT or ALMR?

Do insiders & institutionals hold more shares of ALNT or ALMR?

Which has higher valuation and earnings, ALNT or ALMR?

Is ALNT or ALMR more profitable?

Do analysts rate ALNT or ALMR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALMR vs. The Competition

Alamar Biosciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools